The Gross Margin of Aurisco Pharmaceutical Co Ltd (605116.SS) is 58.92%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 58.92% |
| 2024-12-31 | 57.24% |
| 2023-12-31 | 55.31% |
| 2022-12-31 | 50.85% |
| 2021-12-31 | 49.13% |
| 2020-12-31 | 47.17% |
| 2019-12-31 | 51.17% |
| 2018-12-31 | 47.32% |
| 2017-12-31 | 48.51% |